We caught up with Paul, at the airport, to discuss Elixinol’s progress in the CBD and hemp consumer products and foods markets, which has resulted in over AUD$14 million revenues and profits in Q2 2018.
Paul also talks about the company’s business strategy, and the plans for deploying a recent AUD$40 million capital raise, to expand global sales growth.
Our GDPR privacy policy was updated on August 8, 2022. Visit acast.com/privacy for more information.
Comments (0)